Mardi Gomberg-Maitland, MD

Dr. Mardi Gomberg-Maitland is an expert clinician and researcher in the field of pulmonary heart disease. In recent years, she has participated in dozens of multi-center, multinational research trials to explore new therapies for pulmonary hypertension.

She is a former Doris Duke Clinical Scientist winner for her research in Phase I drug development. She is currently spearheading a Phase I clinical trial with ranolazine. Her current focus is on pulmonary arterial, pulmonary venous hypertension/diastolic dysfunction, biomarker development, risk stratification and pharmacogenomics.

In addition, Dr. Gomberg-Maitland has published numerous articles in medical journals, including Circulation, the New England Journal of Medicine, the Journal of the American College of Cardiology, the American Journal of Respiratory and Critical Care Medicine, Chest, European Respiratory Journal, and the Archives of Internal Medicine.

Practice Location

Duchossois Center for Advanced Medicine 
5758 S. Maryland Avenue 
Chicago, IL 60637

Year Started Practice

2002

Board Certifications

Internal Medicine 
Cardiology

Medical School

Albert Einstein College of Medicine

Residency

New York Presbyterian Hospital-Weill/Cornell Medical Center

Fellowship

Mount Sinai Medical Center, New York

Additional Graduate Degree

Masters in Clinical Epidemiology 
Harvard School of Public Health, Boston

Memberships

American College of Cardiology 
American College of Chest Physicians 
American Heart Association 
American Thoracic Society 
Pulmonary Hypertension Association

Language Spoken

English